Elecsys PTH , Elecsys PTH STAT
Radioimmunoassay, Parathyroid Hormone. 510(k) K231927, from Roche Diagnostics (Indianapolis, IN). Product code CEW, class 2.
As of Nov 20, 2026, K231927 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Mar 22, 2024 after 266 days, with no recalls tied to it in FDA's recall database.
- Review time: 266 days
- Recalls: 0
Elecsys PTH and Elecsys PTH STAT: Immunoassay for the in vitro quantitative determination of intact parathyroid hormone in human serum and plasma for the differential diagnosis of hypercalcemia and hypocalcemia. This assay can be used intraoperatively. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers
- Roche Elecsys Pth Test SystemK070709 · Roche Diagnostics Corp. · Jul 13, 2007
- Access Intact PTHK232791 · Beckman Coulter, Inc. · Mar 1, 2024
- VITROS Immunodiagnostic Products Intact PTH II Reagent PackK221197 · Ortho Clinical Diagnostics · Sep 5, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 30, 2023
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1545
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files